ATXN3 and Huntington disease: Since disruption of CREB activity in the brain triggers neurodegeneration (Mantamadiotis et al., 2002), mHTT-mediated decreases in ATXN3, CBP, and CREB activities might compromise neuronal function and trigger neurotoxicity, further amplifying pro-degenerative output in HD.